Delivery Order SPE2DB22D9304-SPE2DB25FSSM5

Award Date 1/16/25
Potential Completion Date 2/7/25
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $5,207.70 contract is for the delivery of Mirena 52 mg systems, a type of intrauterine contraceptive device. The contract has an ultimate completion date of February 20, 2025 and is not associated with any set-aside designations. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery...
This is a $14,208 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg intrauterine systems, a prescription contraceptive product. The contract has an ultimate completion date of December 18, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,552 delivery order is for the supply of Mirena 52 mg systems, a hormonal intrauterine device used for contraception. The contract is placed under DMS Pharmaceutical Group's $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA, which allows the agency to issue firm...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,736 contract is for the delivery of Mirena 52 mg systems, a type of intrauterine contraceptive device. The contract has an ultimate completion date of November 29, 2024 and is not associated with any set-aside designations. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,552.00, is for the delivery of Mirena 52 mg systems, a type of intrauterine contraceptive device. The contract has an ultimate completion date of October 18, 2024. DMS Pharmaceutical Group Inc. holds a large, single-award Indefinite Delivery Contract (IDC) with the...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $13,024.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg intrauterine systems, a contraceptive product. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDV) SPE2DB with DLA, valued at up to $4,999,999 through 2025, which...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth up to $1,184.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4,564,029,380 units of Mirena 52 mg contraceptive intrauterine systems. The delivery order has an ultimate completion date of April 8, 2024 and was awarded on March 18, 2024. This contract is part of DMS Pharmaceutical Group's existing indefinite delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,168.00 contract is for the delivery of Mirena 52 mg Systems, a contraceptive intrauterine device, with a completion date of March 7, 2024. The contract has no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,184.00, is for the delivery of Mirena 52 mg systems, a type of intrauterine contraceptive device. This order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group that has a ceiling value of up to $499,999,999...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $5,635.30 contract is for the delivery of Mirena 52 mg Systems, a prescription intrauterine contraceptive device. This delivery order is part of a larger single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, valued at $499,999,999 and valid through November 2026. The IDC...
  • SPE2DB22D9304
    Indefinite Delivery Contract
  • SPE2DB22D9304-SPE2DB25FSSM5
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $15,623.10 contract is for the delivery of Mirena 52 mg systems, which are intrauterine devices used for contraception. The contract has an ultimate completion date of February 7, 2025.

DMS Pharmaceutical Group Inc. holds a large Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC allows the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. The award for the Mirena 52 mg systems is not associated with a set-aside designation.

Generated 4/18/25, 2:06 AM